Saltroad, a clinician-led speech and language therapy (SLT) provider, has raised £1.5 million and acquired Ogma, an AI-powered documentation platform purpose-built for SLT practitioners. The round was led by Techstart Ventures, with participation from Ascension, ScaleX, and a group of angel investors.
The Problem: Scale That the System Was Never Designed For
An estimated 1 in 5 children in the UK — around two million — need support with speech, language, and communication. Demand has long outpaced supply, leaving families on waiting lists measured in months or years and therapists buried in administrative overhead.
Saltroad's argument is that this bottleneck isn't inevitable — it's structural. The company gives families direct access to NHS-trained speech and language therapists through a private marketplace model, with:
- No waiting lists
- Therapists matched to a child's specific clinical profile
- Pricing that undercuts traditional private therapy
- A network of over 1,000 therapists across the UK
Where Ogma Fits In
The acquisition of Ogma targets one of the most persistent drains on therapist time: post-session documentation. By embedding Ogma's AI tooling into Saltroad's workflow, raw session data is automatically converted into structured, clinically valid notes — reducing after-hours admin and standardising record quality across the workforce.
The goal isn't to replace clinical judgment. It's to reclaim the hours currently lost to paperwork and redirect them toward direct patient care.
"Too many children wait months, sometimes years, for help during the years that matter most. That isn't a failure of effort from therapists — it's a system that was never built for the scale or variety of need it now faces." — Darren Lester, Co-founder and CEO, Saltroad
Investor Rationale
Both lead investors framed their thesis around the combination of AI augmentation and clinical credibility — not AI as a replacement for therapists.
"The combination of a scalable therapist workforce and purpose-built AI is exactly the kind of ambition we want to support in Northern Ireland." — Audrey Osborne, Partner, Techstart Ventures
"Bringing AI alongside skilled clinicians, rather than in place of them, is the right way to widen access without lowering the bar." — Toyosi Ogedengbe, Partner, Ascension
What's Next
The funding and Ogma integration underpin Saltroad's broader plan to build a scalable, AI-enabled SLT workforce — pairing flexible associate therapist models with tooling designed to increase throughput without compromising clinical quality or therapist wellbeing.
For a sector where the bottleneck has always been time, not talent, the approach is pragmatic: use AI to eliminate friction, and let therapists do what they trained to do.


